Prefilled Syringes Market Overview
The American multinational medical technology business Becton, Dickinson and Company, better known as B.D., produces and markets reagents, instrument systems, and medical devices
Prefilled Syringes Market Size was valued at USD 79.5 billion in 2022. The Prefilled Syringes market industry is projected to grow from USD 83.6 Billion in 2023 to USD 112.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.12% during the forecast period (2023 - 2030).. The minimal drug wastage achieved through the increased in the utility of prefilled syringes has opened an attractive option for the growing pharmaceutical sector to invest. This is expected to promote the prefilled syringe market in the study period. The benefit of self-administration of medication offered by these syringes has increased its consumer based, thereby contributing to the overall growth of the prefilled syringe market.
The biologics and biosimilars sectors are observed as another major promoters of the prefilled syringe market. Other causes that are expected to propel the prefilled syringe Prefilled Syringes Market are persistence of chronic diseases over a long time that necessitate the regular administration of drugs. Increase in chronic diseases, such as; diabetes, is identified to enhance the development of prefilled syringes for parenteral drug delivery is the preferred route of administration for insulin. Ease of use and dosing errors elimination benefits offered prefilled syringe, along with the aforementioned causes can favor the market. Greater dose precision, simplicity in design, and suitability for home use are other advantages of prefilled syringe that is expected to promote the market during the analysis period.
The utility of prefilled syringes for different therapeutics applications, other than conventional uses, such as; vaccine dispensing, has also triggered the demand for the market. The rapid development of the medical industry over the past few years is also likely to contribute significantly to the rise of the market. In addition, the increase in demand for convenient drug delivery methods has paved way for the development of the market. This is due to the pharmaceutical industry pursues modern and more effective methods for introduction solutions for convenient administration of unit dose medication.
Regional Analysis
In Europe, the prefilled syringe market can hold a decent share of the global market. Expansion of geriatric population, growing demand for better quality healthcare services and solutions, ongoing trend of home-based treatment, and hike in healthcare expenditure are causes that are likely to boost EU market. Similar causes are also observed as growth inducers in the Americas region. The Americas is likely to hold the second-largest market portion, following the Asia Pacific region. APAC prefilled syringe market can rise at 10.78% expansion rate in the forecast period. Moreover, factors such as, rapid adoption of plastic devices and modern healthcare developments are, expected to benefit the market in the review period. In the Middle East Asia, the surge in number of public hospitals and private clinics can promote the regional prefilled syringe market. market.
Market Segmentation
The segment assessment of the prefilled syringes market is based out type, end users, material, and design.
The type-based segments of the prefilled syringes market are conventional prefilled syringes and safety prefilled syringes. The conventional prefilled syringes segment is expected to hold the largest share of market by 2024.
The material-based segments of the prefilled syringe market are glass prefilled syringes and plastic prefilled syringes. The plastic syringes segment is expected to garner substantial revenue for the market. The expansion of the plastic syringe segment can be attributed to their increasing utility the pharmaceutical packaging. The glass prefilled syringes segment studies oil siliconized syringes and baked on silicone.
The design-based segments of the market are customized prefilled syringes, dual-chamber prefilled syringes, and single-chamber prefilled syringes. The Dual-chamber prefilled syringes segment can expand at 10.31% CAGR in the forecast tenure. The single-chamber prefilled syringes segment is likely to secure about 56% share for the overall prefilled syringe market by 2024.
The end-user-based segments of market are hospitals & clinics, and ambulatory surgical units among others. The hospitals segment is likely to grow with the rapid CAGR in the study period as the number of private and public hospitals are increasing.
Competitive Analysis
Medtronic, Terumo Corporation, OMPI (A Stevanato Group Company¸ Vetter Pharma International GmbH, Abbott¸ Gerresheimer AG, Nipro Corporation, Baxter, Schott AG, West Pharmaceutical, Becton, Dickinson and Company, and Weigao Group, among others are some top-notch companies that are operating in the prefilled syringes market Players as listed by MRFR.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com